P63 (CKAP4) as an SP-A receptor: Implications for surfactant turnover

Cellular Physiology and Biochemistry

Volumn 25, Issue 1, 2010, Pages 41-54

  Bates, Sandra ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Lung surfactant; P63 CKAP4; Receptor mediated interactions; Receptors; Surfactant protein A; Type II alveolar pneumocytes

Indexed keywords

CLATHRIN; LUNG SURFACTANT; PROTEIN P63; SURFACTANT PROTEIN A;

ENDOCYTOSIS; GENE TARGETING; HUMAN; LUNG ALVEOLUS CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RECEPTOR DENSITY; REVIEW; STRUCTURE ANALYSIS;

MUS;

EID: 73849106694     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000272062     Document Type: Review

References (67)

1. Fisher AB: Lung Surfactant Clearance and Cellular Processing. in Rooney SA, Landes RG (eds): Lung surfactant: cellular and molecular processing Medical Intelligence Unit 5. Austin, TX: Landes Bioscience, 1998, pp 165-189.
2. Khubchandani KR, Snyder JM: Surfactant protein A (SP-A): the alveolus and beyond. Faseb J 2001;15:59-69.
3. Kuroki Y, Mason RJ, Voelker DR: Chemical modification of surfactant protein A alters high affinity binding to rat alveolar type II cells and regulation of phospholipid secretion. J Biol Chem 1988;263:17596-17602.
4. Wright JR, Borchelt JD, Hawgood S: Lung surfactant apoprotein SP-A (26-36 kDa) binds with high affinity to isolated alveolar type II cells. Proc Natl Acad Sci U S A 1989;86:5410-5414.
5. Pastva AM, Wright JR, Williams KL: Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc 2007;4:252-257.
6. Haagsman HP, Hogenkamp A, van Eijk M, Veldhuizen EJ: Surfactant collectins and innate immunity. Neonatology 2008;93:288-294.
7. Bourdon JC: p53 Family isoforms. Curr Pharm Biotechnol 2007;8:332-336.
8. Candi E, Cipollone R, Rivetti di Val Cervo P, Gonfloni S, Melino G, Knight R: p63 in epithelial development. Cell Mol Life Sci 2008;65:3126-3133.
9. Ikegami M, Korfhagen TR, Bruno MD, Whitsett JA, Jobe AH: Surfactant metabolism in surfactant protein A-deficient mice. Am J Physiol 1997;272:L479-485.
10. Ikegami M, Korfhagen TR, Whitsett JA, Bruno MD, Wert SE, Wada K, Jobe AH: Characteristics of surfactant from SPA-deficient mice. Am J Physiol 1998;275:L247-254.
11. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA: Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A 1996;93:9594-9599.
12. Jain D, Dodia C, Bates SR, Hawgood S, Poulain FR, Fisher AB: SP-A is necessary for increased clearance of alveolar DPPC with hyperventilation or secretagogues. Am J Physiol Lung Cell Mol Physiol 2003;284:L759-765.
13. Bates SR, Dodia C, Tao JQ, Fisher AB: Surfactant protein-A plays an important role in lung surfactant clearance: evidence using the surfactant protein-A gene-targeted mouse. Am J Physiol Lung Cell Mol Physiol 2008;294:L325-333.
14. Voss T, Eistetter H, Schafer KP, Engel: Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J Mol Biol 1988;201:219-227.
15. McCormack FX: Structure, processing and properties of surfactant protein A. Biochim Biophys Acta 1998;1408:109-131.
16. Palaniyar N, McCormack FX, Possmayer F, Harauz G: Three-dimensional structure of rat surfactant protein A trimers in association with phospholipid monolayers. Biochemistry 2000;39:6310-6316.
17. Palaniyar N, Ridsdale RA, Holterman CE, Inchley K, Possmayer F, Harauz G: Structural changes of surfactant protein A induced by cations reorient the protein on lipid bilayers. J Struct Biol 1998;122:297-310.
18. Head JF, Mealy TR, McCormack FX, Seaton BA: Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem 2003;278:43254-43260.
19. Kuroki Y, Mason RJ, Voelker DR: Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 1988;263:3388-3394.
20. Murata Y, Kuroki Y, Akino T: Role of the C-terminal domain of pulmonary surfactant protein A in binding to alveolar type II cells and regulation of phospholipid secretion. Biochem J 1993;291:71-76.
21. Kuroki Y, McCormack FX, Ogasawara Y, Mason RJ, Voelker DR: Epitope mapping for monoclonal antibodies identifies functional domains of pulmonary surfactant protein A that interact with lipids. J Biol Chem 1994;269:29793- 29800.
22. Hiraike N, Sohma H, Kuroki Y, Akino T: Epitope mapping for monoclonal antibody against human surfactant protein A (SP-A) that alters receptor binding of SP-A and the SP-A-dependent regulation of phospholipid secretion by alveolar type II cells. Biochim Biophys Acta 1995;1257:214-222.
23. Kuroki Y, Mason RJ, Voelker DR: Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A. Proc Natl Acad Sci U S A 1988;85:5566-5570. (Pubitemid 18207082)
24. Chen Q, Bates SR, Fisher AB: Secretagogues increase the expression of surfactant protein A receptors on lung type II cells. J Biol Chem 1996;271:25277-25283.
25. Bates SR, Kazi AS, Tao JQ, Yu KJ, Gonder DS, Feinstein SI, Fisher AB: Role of P63 (CKAP4) in binding of surfactant protein-A to type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 2008;295:L658-669.
26. Chroneos ZC, Abdolrasulnia R, Whitsett JA, Rice WR, Shepherd VL: Purification of a cell-surface receptor for surfactant protein A. J Biol Chem 1996;271:16375-16383.
27. Goldstein JL, Brown MS, Anderson RG, Russell DW, Schneider WJ: Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. Annu Rev Cell Biol 1985;1:1-39.
28. Ryan RM, Morris RE, Rice WR, Ciraolo G, Whitsett JA: Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells. J Histochem Cytochem 1989;37:429-440.
29. Stevens PA, Wissel H, Zastrow S, Sieger D, Zimmer KP: Surfactant protein A and lipid are internalized via the coated-pit pathway by type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 2001;280:L141-151.
30. Jain D, Dodia C, Fisher AB, Bates SR: Pathways for clearance of surfactant protein A from the lung. Am J Physiol Lung Cell Mol Physiol 2005;289:L1011-1018.
31. Stevens PA, Wissel H, Sieger D, Meienreis-Sudau V, Rustow B: Identification of a new surfactant protein A binding protein at the cell membrane of rat type II pneumocytes. Biochem J 1995;308:77-81.
32. Strayer DS, Yang S, Jerng HH: Surfactant protein A-binding proteins. Characterization and structures. J Biol Chem 1993;268:18679-18684.
33. Kresch MJ, Christian C, Lu H: Isolation and partial characterization of a receptor to surfactant protein A expressed by rat type II pneumocytes. Am J Respir Cell Mol Biol 1998;19:216-225.
34. Gupta N, Manevich Y, Kazi AS, Tao JQ, Fisher AB, Bates SR: Identification and characterization of p63 (CKAP4/ ERGIC-63/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 2006;291:L436-446.
35. Tino MJ, Wright JR: Interactions of surfactant protein A with epithelial cells and phagocytes. Biochim Biophys Acta 1998;1408:241-263.
36. Strayer DS: Identification of a cell membrane protein that binds alveolar surfactant. Am J Pathol 1991;138:1085-1095.
37. Chen Q, Fisher AB, Strayer DS, Bates SR: Mechanism for secretagogue-induced surfactant protein A binding to lung epithelial cells. Am J Physiol 1998;275:L38-46.
38. Strayer DS, Pinder R, Chander A: Receptor-mediated regulation of pulmonary surfactant secretion. Exp Cell Res 1996;226:90-97.
39. Wissel H, Looman AC, Fritzsche I, Rustow B, Stevens PA: SP-A-binding protein BP55 is involved in surfactant endocytosis by type II pneumocytes. Am J Physiol 1996;271:L432-440.
40. Samten B, Townsend JC, Sever-Chroneos Z, Pasquinelli V, Barnes PF, Chroneos ZC: An antibody against the surfactant protein A (SP-A)-binding domain of the SP-A receptor inhibits T cell-mediated immune responses to Mycobacterium tuberculosis. J Leukoc Biol 2008;84:115-123.
41. Borron P, McCormack FX, Elhalwagi BM, Chroneos ZC, Lewis JF, Zhu S, Wright JR, Shepherd VL, Possmayer F, Inchley K, Fraher LJ: Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am J Physiol 1998;275:L679-686.
42. Yang CH, Szeliga J, Jordan J, Faske S, Sever-Chroneos Z, Dorsett B, Christian RE, Settlage RE, Shabanowitz J, Hunt DF, Whitsett JA, Chroneos ZC: Identification of the surfactant protein A receptor 210 as the unconventional myosin 18A. J Biol Chem 2005;280:34447-34457.
43. Schweizer A, Ericsson M, Bachi T, Griffiths G, Hauri HP: Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway. J Cell Sci 1993;104:671-683.
44. Razzaq TM, Bass R, Vines DJ, Werner F, Whawell SA, Ellis V: Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4). J Biol Chem 2003;278:42679-42685.
45. Conrads TP, Tocci GM, Hood BL, Zhang CO, Guo L, Koch KR, Michejda CJ, Veenstra TD, Keay SK: CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients. J Biol Chem 2006;281:37836-37843.
46. Schweizer A, Rohrer J, Slot JW, Geuze HJ, Kornfeld S: Reassessment of the subcellular localization of p63. J Cell Sci 1995;108:2477-2485.
47. Schweizer A, Rohrer J, Jeno P, DeMaio A, Buchman T G, Hauri HP: A reversibly palmitoylated resident protein (p63) of an ER-Golgi intermediate compartment is related to a circulatory shock resuscitation protein. J Cell Sci 1993;104:685-694.
48. Klopfenstein DR, Kappeler F, Hauri HP: A novel direct interaction of endoplasmic reticulum with microtubules. Embo J 1998;17:6168-6177.
49. Klopfenstein DR, Klumperman J, Lustig A, Kammerer RA, Oorschot V, Hauri HP: Subdomain-specific localization of CLIMP-63 (p63) in the endoplasmic reticulum is mediated by its luminal alpha-helical segment. J Cell Biol 2001;153:1287-1300.
50. Vedrenne C, Klopfenstein DR, Hauri HP: Phosphorylation controls CLIMP-63-mediated anchoring of the endoplasmic reticulum to microtubules. Mol Biol Cell 2005;16:1928-1937.
51. Schweizer A, Rohrer J, Hauri HP, Kornfeld S: Retention of p63 in an ER-Golgi intermediate compartment depends on the presence of all three of its domains and on its ability to form oligomers. J Cell Biol 1994;126:25-39.
52. Vedrenne C, Hauri HP: Morphogenesis of the endoplasmic reticulum: beyond active membrane expansion. Traffic 2006;7:639-646.
53. Li SS: Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 2005;390:641-653.
54. Schweizer A, Rohrer J, Kornfeld S: Determination of the structural requirements for palmitoylation of p63. J Biol Chem 1995;270:9638-9644.
55. Zhang J, Planey SL, Ceballos C, Stevens SM, Jr., Keay SK, Zacharias DA: Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method. Mol Cell Proteomics 2008;7:1378-1388.
56. Resh MD: Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE 2006;2006:re14.
57. Monigatti F, Hekking B, Steen H: Protein sulfation analysis-A primer. Biochim Biophys Acta 2006;1764:1904-1913.
58. Moore KL: The biology and enzymology of protein tyrosine O-sulfation. J Biol Chem 2003;278:24243-24246.
59. Wilkins PP, Moore KL, McEver RP, Cummings RD: Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J Biol Chem 1995;270:22677-22680.
60. Leyte A, van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP, Mertens K, van Mourik JA: Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1991;266:740-746.
61. Costagliola S, Panneels V, Bonomi M, Koch J, Many MC, Smits G, Vassart G: Tyrosine sulfation is required for agonist recognition by glycoprotein hormone receptors. Embo J 2002;21:504-513.
62. Fisher AB, Arad I, Dodia C, Chander A, Feinstein SI: cAMP increases synthesis of surfactant-associated protein A by perfused rat lung. Am J Physiol 1991;260:L226-233.
63. Keay SK, Szekely Z, Conrads TP, Veenstra TD, Barchi JJ, Jr., Zhang CO, Koch KR, Michejda CJ: An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci U S A 2004;101:11803-11808.
64. Herbein JF, Savov J, Wright JR: Binding and uptake of surfactant protein D by freshly isolated rat alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 2000;278:L830-839.
65. Moreland JL, Gramada A, Buzko OV, Zhang Q, Bourne PE: The Molecular Biology Toolkit (MBT): a modular platform for developing molecular visualization applications. BMC Bioinformatics 2005;6:21.
66. Hulo N, Bairoch A, Bulliard V, Cerutti L, Cuche BA, de Castro E, Lachaize C, Langendijk-Genevaux PS, Sigrist CJ: The 20 years of PROSITE. Nucleic Acids Res 2008;36:D245-249.
67. Wissel H, Looman AC, Fritzsche I, Rustow B and Stevens PA: SP-A-binding protein BP55 is involved in surfactant endocytosis by type II pneumocytes. Am J Physiol. Lung Cell Mol Physiol 1996;271:L432-440.